These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16934455)

  • 1. Structure-based design of a novel thiazolone scaffold as HCV NS5B polymerase allosteric inhibitors.
    Yan S; Appleby T; Larson G; Wu JZ; Hamatake R; Hong Z; Yao N
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5888-91. PubMed ID: 16934455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel thiazolones as HCV NS5B polymerase allosteric inhibitors: Further designs, SAR, and X-ray complex structure.
    Yan S; Larson G; Wu JZ; Appleby T; Ding Y; Hamatake R; Hong Z; Yao N
    Bioorg Med Chem Lett; 2007 Jan; 17(1):63-7. PubMed ID: 17049849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-nucleoside inhibitors of HCV NS5B polymerase. Part 1: Synthetic and computational exploration of the binding modes of benzothiadiazine and 1,4-benzothiazine HCV NS5b polymerase inhibitors.
    Hendricks RT; Fell JB; Blake JF; Fischer JP; Robinson JE; Spencer SR; Stengel PJ; Bernacki AL; Leveque VJ; Le Pogam S; Rajyaguru S; Najera I; Josey JA; Harris JR; Swallow S
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3637-41. PubMed ID: 19447623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isothiazoles as active-site inhibitors of HCV NS5B polymerase.
    Yan S; Appleby T; Gunic E; Shim JH; Tasu T; Kim H; Rong F; Chen H; Hamatake R; Wu JZ; Hong Z; Yao N
    Bioorg Med Chem Lett; 2007 Jan; 17(1):28-33. PubMed ID: 17049853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based virtual screening, synthesis and SAR of novel inhibitors of hepatitis C virus NS5B polymerase.
    Talele TT; Arora P; Kulkarni SS; Patel MR; Singh S; Chudayeu M; Kaushik-Basu N
    Bioorg Med Chem; 2010 Jul; 18(13):4630-8. PubMed ID: 20627595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular design and synthesis of HCV inhibitors based on thiazolone scaffold.
    Al-Ansary GH; Ismail MA; Abou El Ella DA; Eid S; Abouzid KA
    Eur J Med Chem; 2013 Oct; 68():19-32. PubMed ID: 23933047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of thiazolone-based sulfonamides as inhibitors of HCV NS5B polymerase.
    Ding Y; Smith KL; Varaprasad CV; Chang E; Alexander J; Yao N
    Bioorg Med Chem Lett; 2007 Feb; 17(3):841-5. PubMed ID: 16990004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SAR and mode of action of novel non-nucleoside inhibitors of hepatitis C NS5b RNA polymerase.
    Powers JP; Piper DE; Li Y; Mayorga V; Anzola J; Chen JM; Jaen JC; Lee G; Liu J; Peterson MG; Tonn GR; Ye Q; Walker NP; Wang Z
    J Med Chem; 2006 Feb; 49(3):1034-46. PubMed ID: 16451069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiazolone-acylsulfonamides as novel HCV NS5B polymerase allosteric inhibitors: convergence of structure-based drug design and X-ray crystallographic study.
    Yan S; Appleby T; Larson G; Wu JZ; Hamatake RK; Hong Z; Yao N
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1991-5. PubMed ID: 17276060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinolones as HCV NS5B polymerase inhibitors.
    Kumar DV; Rai R; Brameld KA; Somoza JR; Rajagopalan R; Janc JW; Xia YM; Ton TL; Shaghafi MB; Hu H; Lehoux I; To N; Young WB; Green MJ
    Bioorg Med Chem Lett; 2011 Jan; 21(1):82-7. PubMed ID: 21145235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of pyrano[3,4-b]indoles as potent and selective HCV NS5B polymerase inhibitors.
    Gopalsamy A; Lim K; Ciszewski G; Park K; Ellingboe JW; Bloom J; Insaf S; Upeslacis J; Mansour TS; Krishnamurthy G; Damarla M; Pyatski Y; Ho D; Howe AY; Orlowski M; Feld B; O'Connell J
    J Med Chem; 2004 Dec; 47(26):6603-8. PubMed ID: 15588095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-nucleoside inhibitors of HCV polymerase NS5B. Part 2: Synthesis and structure-activity relationships of benzothiazine-substituted quinolinediones.
    de Vicente J; Hendricks RT; Smith DB; Fell JB; Fischer J; Spencer SR; Stengel PJ; Mohr P; Robinson JE; Blake JF; Hilgenkamp RK; Yee C; Adjabeng G; Elworthy TR; Tracy J; Chin E; Li J; Wang B; Bamberg JT; Stephenson R; Oshiro C; Harris SF; Ghate M; Leveque V; Najera I; Le Pogam S; Rajyaguru S; Ao-Ieong G; Alexandrova L; Larrabee S; Brandl M; Briggs A; Sukhtankar S; Farrell R; Xu B
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3642-6. PubMed ID: 19457662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The discovery and structure-activity relationships of pyrano[3,4-b]indole based inhibitors of hepatitis C virus NS5B polymerase.
    LaPorte MG; Draper TL; Miller LE; Blackledge CW; Leister LK; Amparo E; Hussey AR; Young DC; Chunduru SK; Benetatos CA; Rhodes G; Gopalsamy A; Herbertz T; Burns CJ; Condon SM
    Bioorg Med Chem Lett; 2010 May; 20(9):2968-73. PubMed ID: 20347591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dynamics simulations and structure-based rational design lead to allosteric HCV NS5B polymerase thumb pocket 2 inhibitor with picomolar cellular replicon potency.
    Hucke O; Coulombe R; Bonneau P; Bertrand-Laperle M; Brochu C; Gillard J; Joly MA; Landry S; Lepage O; Llinàs-Brunet M; Pesant M; Poirier M; Poirier M; McKercher G; Marquis M; Kukolj G; Beaulieu PL; Stammers TA
    J Med Chem; 2014 Mar; 57(5):1932-43. PubMed ID: 23773186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery of benzimidazole 5-carboxylic amide derivatives with low-nanomolar potency.
    Beaulieu PL; Bös M; Bousquet Y; DeRoy P; Fazal G; Gauthier J; Gillard J; Goulet S; McKercher G; Poupart MA; Valois S; Kukolj G
    Bioorg Med Chem Lett; 2004 Feb; 14(4):967-71. PubMed ID: 15013003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric inhibitors of hepatitis C virus NS5B polymerase thumb domain site II: structure-based design and synthesis of new templates.
    Malancona S; Donghi M; Ferrara M; Martin Hernando JI; Pompei M; Pesci S; Ontoria JM; Koch U; Rowley M; Summa V
    Bioorg Med Chem; 2010 Apr; 18(8):2836-48. PubMed ID: 20363140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel potent HCV NS5B polymerase non-nucleoside inhibitors bearing a fused benzofuran scaffold.
    Zhong M; Peng E; Huang N; Huang Q; Huq A; Lau M; Colonno R; Li L
    Bioorg Med Chem Lett; 2018 Mar; 28(5):963-968. PubMed ID: 29422387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of anthranilic acid derivatives as a novel class of allosteric inhibitors of hepatitis C NS5B polymerase.
    Nittoli T; Curran K; Insaf S; DiGrandi M; Orlowski M; Chopra R; Agarwal A; Howe AY; Prashad A; Floyd MB; Johnson B; Sutherland A; Wheless K; Feld B; O'Connell J; Mansour TS; Bloom J
    J Med Chem; 2007 May; 50(9):2108-16. PubMed ID: 17402724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a novel series of non-nucleoside thumb pocket 2 HCV NS5B polymerase inhibitors.
    Stammers TA; Coulombe R; Rancourt J; Thavonekham B; Fazal G; Goulet S; Jakalian A; Wernic D; Tsantrizos Y; Poupart MA; Bös M; McKercher G; Thauvette L; Kukolj G; Beaulieu PL
    Bioorg Med Chem Lett; 2013 May; 23(9):2585-9. PubMed ID: 23545108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of HCV NS5B thumb site I inhibitors: core-refining from benzimidazole to indole scaffold.
    Zhao F; Liu N; Zhan P; Jiang X; Liu X
    Eur J Med Chem; 2015 Apr; 94():218-28. PubMed ID: 25768704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.